Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma

被引：47
|
作者：
Orchard, K
Barrington, S
Buscombe, J
Hilson, A
Prentice, HG
Mehta, A
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Haematol, London, England
[2] Kings & St Thomass Hosp, Clin PET Ctr, London, England
[3] UCL Royal Free & Univ Coll Med Sch, Dept Nucl Med, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 01期
关键词：
myeloma; FDG-PET; imaging; occult disease; non-secretory;
D O I：
10.1046/j.1365-2141.2002.03407.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Positron emission tomography with 2-deoxy-2-[18]fluoro-d-glucose (FDG-PET) imaging has been extensively used to detect occult metastatic malignant lesions in patients with carcinoma. We describe its use in three patients with multiple myeloma, each representing a particular clinical situation in which this imaging modality offered advantages over plain radiography, computerized tomography or magnetic resonance imaging. FDG-PET provides a whole body image showing sites of occult disease. This is of particular value in patients with non-secretory myeloma, solitary plasmacytoma or for those that relapse with focal disease following autologous or allogeneic stem cell transplantation.
引用
收藏
页码：133 / 135
页数：3
相关论文
共 50 条
  • [1] Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
    Albin, RL
    Minoshima, S
    DAmato, CJ
    Frey, KA
    Kuhl, DA
    Sima, AAF
    NEUROLOGY, 1996, 47 (02) : 462 - 466
  • [2] Role of combined fluoro-deoxyglucose positron emission tomography with computed tomography for bladder tumor
    Mandal, Swarnendu
    Yadav, Manoj
    Goel, Apul
    INDIAN JOURNAL OF UROLOGY, 2011, 27 (03) : 428 - +
  • [3] Value of (18)fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma
    Bender, H
    Kirst, J
    Palmedo, H
    Schomburg, A
    Wagner, U
    Ruhlmann, J
    Biersack, HJ
    ANTICANCER RESEARCH, 1997, 17 (3B) : 1687 - 1692
  • [4] (18F) fluoro-deoxyglucose positron emission tomography in patients with fever of unknown origin
    Blockmans, D
    ACTA CLINICA BELGICA, 2004, 59 (03): : 134 - 137
  • [5] Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck
    Price, T.
    Pickles, J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2006, 120 (04): : 334 - 337
  • [6] The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis
    Blockmans, D
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : S15 - S22
  • [7] Whole body fluoro-deoxyglucose (FDG) scanning in multiple myeloma (MM).
    Durie, BGM
    Waxman, AD
    D'Agnolo, A
    BLOOD, 1998, 92 (10) : 262B - 263B
  • [8] Whole body fluoro-deoxyglucose (FDG) scanning in multiple myeloma (MM).
    Durie, BGM
    Waxman, AD
    D'Agnolo, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 61P - 61P
  • [9] INFLUENCE OF FFA AND INSULIN ON MYOCARDIAL GLUCOSE-UPTAKE IN HYPERGLYCEMIA ASSESSED BY POSITRON EMISSION TOMOGRAPHY AND FLUORO-DEOXYGLUCOSE
    MONTI, LD
    LANDONI, C
    STEFANI, I
    MORESCO, RM
    VEZZOLI, M
    LUCIGNANI, G
    PIATTI, PM
    FAZIO, F
    POZZA, G
    DIABETOLOGIA, 1993, 36 : A7 - A7
  • [10] Clinical value of [18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin
    Blockmans, D
    Knockaert, D
    Maes, A
    De Caestecker, J
    Stroobants, S
    Bobbaers, H
    Mortelmans, L
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (02) : 191 - 196
12345